Preparation and biological activity of retinoic acid analogs containing an aromatic ring

Letters in Drug Design and Discovery

Volumn 3, Issue 2, 2006, Pages 118-122

  Wada, Akimori ^a   Mizuguchi, Yukari ^a   Shinmen, Masaki ^a   Ito, Masayoshi ^a   Nakagawa, Kimie ^a   Okano, Toshio ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Coupling reaction; Enol triflate; RAR; Retinoic acid analogs; RXR

Indexed keywords

ALKENE DERIVATIVE; AROMATIC COMPOUND; BENZOFURAN DERIVATIVE; ETRETIN; ETRETINATE; INDENE DERIVATIVE; PALLADIUM; RETINOIC ACID DERIVATIVE; RETINOID X RECEPTOR; TRIFLUOROMETHANESULFONIC ACID;

APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CATALYSIS; CELL STRAIN HL 60; CONTROLLED STUDY; CROSS COUPLING REACTION; DRUG ACTIVITY; DRUG DESIGN; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 33645858557     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018006775789711     Document Type: Article

References (34)

1. Mangelsdorf, D. J.; Umesono, K.; Evans, R. M. In The Retinoids, 2nd ed., Sporn, M. B.; Roberts, A. B.; Goodman, D. S., Eds.; Raven: New York, 1994, pp. 319.
2. (a) Heyman, R. A.; Mangelsdorf, D. J.; Dyck, J. A.; Stein, R. B.; Eichele, G.; Evans, R. M.; Thaller, C. Cell, 1992, 68, 397;
3. (b) Hong, W. K.; Sporn, M. B. Science, 1997, 278, 1073.
4. (a) Petkiovich, M.; Brand, N. J.; Krust, A.; Chambon, P. Nature, 1987, 330, 624;
5. (b) Giguere, V.; Ong, E. S.; Segui, P.; Evans, R. M. Nature, 1987, 330, 624;
6. (c) Krust, A.; Kastner, P.; Petkiovich, M.; Zelent, A.; Chambon, P. Proc. Natl. Acad. USA, 1989, 86, 5310.
7. (a) Heyman, R. A.; Mangelsdorf, D. J.; Dyck, J. A.; Stein, R. B.; Eichele, G.; Evans, R. M.; Thaller, C. Cell, 1992, 68, 397;
8. (b) Levin, A. A.; Sturzenbecker, L. J.; Kazmer, S.; Bosakowski, T.; Huselton, C.; Allenby, G.; Speck, J.; Kratzeisen, C.; Rosenberger, M.; Lovey, A.; Grippo, J. F. Nature, 1992, 355, 359.
9. For recent selected examples, see: (a) Brown, C. W.; Liu, S.; Klucik, J.; Berlin, K. D.; Brennan, P. J.; Kaur, D.; Benbrook, D. M. J. Med. Chem., 2004, 47, 1008;
10. (b) Ohta, K.; Iijima, T.; Kawachi, E.; Kagechika, H.; Endo, Y. Bioorg. Med.. Chem. Lett., 2004, 14, 5913;
11. (c) Alvarez, R.; Vega, M. J.; Kammerer, S.; Rossin, A.; Germain, P.; Gronemeyer, H.; de Lera, A. R. Bioorg. Med. Chem. Lett., 2004, 14, 6117;
12. (d) Haffner, C. D.; Lenhard, J. M.; Miller, A. B.; McDougald, D. L.; Dwornik, K.; Ittoop, O. R.; Gampe, Jr. R. T.; Xu, H. E.; Blanchard, S.; Montana, V. G.; Consler, T. G.; Bledsoe, R. K.; Ayscue, A.; Croom, D. J. Med. Chem., 2004, 47, 2010;
13. (e) Ivanova, D.; Rossin, A.; Gronemeyer, H.; Valla, A.; Cartier, D.; Guillou, R. L.; Labia, R, Bioorg. Med. Chem. Lett., 2004, 14, 4257;
14. (f) Michellys, P. Y.; D'Arrigo, .J; Grese, T. A.; Karanewsky, D. S.; Leibowitz, M. D.; Mais, D. A.; Mapes, C. M.; Reifel-Miller, A.; Rungta, D.; Boehm, M. F. Bioorg. Med. Chem. Lett., 2004, 14, 1593;
15. (g) Michellys, P. Y.; Boehm, M. F.; Chen, J. H.; Grese, T. A.; Karanewsky, D. S.; Leibowitz, M. D.; Liu, S.; Mais, D. A.; Mapes, C. M.; Reifel-Miller, A.; Ogilvie, K.; Rungta, D.; Thompson, A. W.; Tyhonas, J. S.; Yumibe, N.; Ardecky, R. J. Bioorg. Med. Chem. Lett., 2003, 13, 4071;
16. (h) Farner, L. J.; Jeong, L. Z.; Lamph, W. W.; Osburn, D. L.; Croston, G.; Flatten, K. S.; Heyman, R. A.; Nadzan, A. M. Bioorg. Med. Chem. Lett., 2003, 13, 261.
17. (a) Watson, A. B. Cancer Detect Prev., 1986, 9, 161;
18. (b) Hong, W. K.; Endicott, J.; Itri, L. M.; Doos, W.; Batsakis, J. G.; Bell, R.; Fofonoff, S.; Byers, R.; Atkinson, E. N.; Vanghan, C. N. Eur. J. Med., 1986, 315, 1501;
19. (c) Magis, N. L.; Blummel, J. J.; Kerkhof, P. C.; Gerritsen, R. M. Eur. J. Dermatol., 2000, 10, 517.
20. (a) Wada, A.; Hiraishi, S.; Ito, M. Chem. Pharm. Bull., 1994, 42, 757;
21. (b) Wada, A.; Tanaka, Y.; Fujioka, N.; Ito, M. Bioorg. Med. Chem. Lett., 1996, 6, 2049;
22. (c) Wada, A.; Fujioka, N.; Tanaka, Y.; Ito. M. J. Org. Chem., 2000, 65, 2438.
23. (a) Wada, A.; Nomoto, Y.; Tano, K.; Yamashita, E.; Ito, M. Chem. Pharm. Bull., 2000, 48, 1391;
24. (b) Wada, A.; Gobindarajulu, B.; Shimomoto, S.; Ito, M. Synlett., 2001, 1759;
25. (c) Wada, A.; Fukunaga, K.; Ito, M. Synlett, 2001, 800;
26. (d) Wada, A.; Fukunaga, K.; Ito, M.; Mizuguchi, Y.; Nakagawa, K.; Okano, T. Bioorg. Med. Chem., 2004, 12, 3931.
27. (a) Betzer, J. F.; Delaloge, F.; Muller, B.; Pancrazi, A.; Prunet, J. J. Org. Chem., 1997, 62, 7768;
28. (b) Havránek, M.; Dvorák, D. Synthesis, 1998, 1264.
29. Farina, V.; Krishnan, B. J. Am. Chem. Soc., 1991, 113, 9585.
30. The structures of these compounds were determined on the basis of their spectral data (IR, NMR and MS).
31. (a) Kurokawa, R.; Söderström, M.; Hörlein, A.; Halachimi, S.; Brown, M.; Rosenfeld, M. G.; Glass, C. K. Nature, 1995, 377, 451;
32. (b) Westin, S.; Kurokawa, R.; Nolte, R. T.; Wisely, G. B.; Mclnerney, R.; Rose, D. W.; Milburn, M. V.; Rosenfeld, M. G.; Glass, C. K.; Nature, 1998, 395, 199;
33. (c) Mackenna, N. J.; O'Malley, B. W. Cell, 2002, 108, 465.
34. Although there are a number of reports for a similar coupling reaction that takes place between an enol triflate derived from a ketone or lactone, there are few that deal with the coupling reaction of enol triflate derived from a lactam. See; Sandosham, J.; Undheim, K.; Rice, F. Heterocycles, 1993, 35, 235.